| 1 |
28104514 | Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells. | 2017 Apr |
1 |
| 2 |
25248321 | All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses. | 2015 Jan |
1 |
| 3 |
26107189 | Influence of Endosomal Escape and Degradation of α-Galactosylceramide Loaded Liposomes on CD1d Antigen Presentation. | 2015 Aug 3 |
1 |
| 4 |
23885215 | Expression of CD1c enhances human invariant NKT cell activation by α-GalCer. | 2013 |
2 |
| 5 |
21575695 | Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles. | 2012 Feb 14 |
1 |
| 6 |
18006319 | Glycolipids as immunostimulating agents. | 2008 Feb 1 |
1 |
| 7 |
18671950 | Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells. | 2008 Sep 15 |
2 |
| 8 |
17071611 | An N-linked glycan modulates the interaction between the CD1d heavy chain and beta 2-microglobulin. | 2006 Dec 29 |
1 |
| 9 |
11970881 | Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. | 2002 Apr |
1 |
| 10 |
12076157 | Synthesis of alpha-galactosyl ceramide, a potent immunostimulatory agent. | 2002 Jun 28 |
1 |
| 11 |
12360465 | Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. | 2002 Oct |
1 |
| 12 |
9782129 | CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. | 1998 Oct 19 |
2 |